Former Isotechnika CEO Yatscoff to boost Alberta pharmaceutical start-ups
EDMONTON, Nov. 29 /CNW/ - TEC Edmonton and the Alberta Heritage
Foundation for Medical Research (AHFMR) today announced the appointment of
Dr. Randall Yatscoff as TEC Edmonton's new Executive in Residence. Dr.
Yatscoff will focus on providing strategic guidance, business planning and
management expertise to a group of early stage start-up companies, with a
focus on pharmaceuticals.
Dr. Yatscoff was previously President and CEO of Isotechnika (ISA: TSX),
a leading Canadian biotechnology company focused on the discovery and
development of immunosuppressive drugs. During his 10-year tenure, Isotechnika
raised close to $200 million through various equity financings. The company
began as a spin-off company from the University of Alberta.
Prior to joining Isotechnika in 1996, Dr. Yatscoff spent 16 years in
academic appointments at the University of Western Ontario, University of
Manitoba and the University of Alberta. Dr. Yatscoff retains a position as
Adjunct Professor in the Faculty of Medicine at the University of Alberta.
Dr. Yatscoff is also chairman of the board of St. Joseph's College at the
University of Alberta. He has over 200 publications in peer-reviewed journals
and holds more than 20 patents. He is also a board member and consultant to
CardioMetabolics, a University of Alberta spin-off company focused on the
treatment of cardiovascular disease and other metabolic diseases, and a
consultant with Isotechnika.
The Executive in Residence program helps improve the viability and growth
potential of new start-up technology companies. With support from AHFMR's
ForeFront Program and other partner organizations, TEC Edmonton recruits
experienced senior managers from specific industries to provide free strategic
guidance, business planning, and management stewardship to qualified early
stage startup companies. The goal of the program is to have the individual
leave TEC Edmonton before or at the end of their two-year appointment to
become a senior manager of one of the companies they have helped to develop.
About TEC Edmonton (www.tecedmonton.com)
A joint venture of the University of Alberta and Edmonton Economic
Development Corporation, TEC Edmonton is committed to providing investors with
access to high-growth, advanced-technology opportunities in the form of new
inventions, innovations, or early stage ventures created in the Edmonton
region. TEC Edmonton acts as the exclusive technology transfer office for the
University of Alberta, the province's largest research institution, with
nearly 13,000 academic and support staff and over 36,000 students at its
About AHFMR (www.ahfmr.ab.ca)
The Alberta Heritage Foundation for Medical Research was established in
1980 by the Government of Alberta with an endowment of $300 million to support
a balanced, long-term program of biomedical and health research based in
Alberta. Since 1980, the Foundation has contributed over $900 million to the
Alberta medical research community. AHFMR's ForeFront program is the
province's longest running technology commercialization program. It supports
researchers and innovators applying new health-related ideas and scientific
discoveries in ways that will lead to improved health. The ForeFront Program
focuses in three main areas of support: career, industry, and innovation.
ForeFront has provided a total of more than $25 million in support to more
than 300 people and projects since 1985.
For further information:
For further information: and interview requests: David Cox, CEO, TEC
Edmonton, Telephone: (780) 492-8318